Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
about
3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders.Edaravone combined with Schwann cell transplantation may repair spinal cord injury in rats.Hyperbaric oxygen therapy combined with Schwann cell transplantation promotes spinal cord injury recovery.Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
P2860
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@ast
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@en
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@nl
type
label
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@ast
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@en
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@nl
prefLabel
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@ast
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@en
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@nl
P2093
P1433
P1476
Treatment of experimental spinal cord injury with 3β-methoxy-pregnenolone.
@en
P2093
Etienne Emile Baulieu
Paul Robel
Sebastien David
Yann Duchossoy
P356
10.1016/J.BRAINRES.2011.05.065
P407
P577
2011-06-12T00:00:00Z